In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series F financing brings £25mm to Oxford Nanopore Technologies

Executive Summary

Oxford Nanopore Technologies Ltd. (formerly Oxford NanoLabs; single-molecule DNA sequencing and protein analysis) has raised £25mm ($41mm) in what is assumed to be its Series F round. Returning and first-time institutional and individual investors based in the UK and US participated, including Lansdowne Partners, seed backer IP Group, Invesco Perpetual, Redmile Group, and the company’s strategic partner Illumina. Taking into account the new financing, Oxford has accumulated £74mm to date.
Deal Industry
  • Biotechnology
    • Nanotechnology, Chips, etc.
  • Research, Analytical Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies